Threshold crossing of device-based intrathoracic impedance trends identifies relatively increased mortality risk

European Heart Journal

Volumn 33, Issue 17, 2012, Pages 2189-2196

  Tang, Wai Hong Wilson ^a   Warman, Eduardo N ^b   Johnson, James W ^b   Small, Roy S ^c   Heywood, James Thomas ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEDTRONIC INC   (United States)

^c The Heart Group   (United States)

^d SCRIPPS CLINIC   (United States)

Author keywords

Heart failure; Intrathoracic impedance; Prognosis

Indexed keywords

AGED; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; IMPEDANCE AUDIOMETRY; IMPLANT; INTRATHORACIC IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SHOCK;

ATRIAL FIBRILLATION; CARDIOGRAPHY, IMPEDANCE; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MONITORING, AMBULATORY; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 84866088896     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs121     Document Type: Review

References (24)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, American Heart Association Statistics Committee and Stroke Statistics S. Heart disease and stroke statistics\-2011 update: a report from the American Heart Association. Circulation 2011;123:e18-e209.
2. Merchant FM, Dec GW, Singh JP. Implantable sensors for heart failure. Circ Arrhythm Electrophysiol 2010;3:657-667.
3. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010;55:1803-1810.
4. Soga Y, Ando K, Arita T, Hyodo M, Goya M, Iwabuchi M, Nobuyoshi M. Efficacy of fluid assessment based on intrathoracic impedance monitoring in patients with systolic heart failure. Circ J 2010;75:129-134.
5. Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, Oliva F, Perego GB, Varbaro A, Denaro A, Valsecchi S, Vergara G. Monitoring intrathor-acic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol 2009;32:363-370.
6. Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail 2009;15:475-481.
7. Perego GB, Landolina M, Vergara G, Lunati M, Zanotto G, Pappone A, Lonardi G, Speca G, Iacopino S, Varbaro A, Sarkar S, Hettrick DA, Denaro A. Implantable CRT device diagnostics identify patients with increased risk for heart failure hos-pitalization. J Interv Card Electrophysiol 2008;23:235-242.
8. Maines M, Catanzariti D, Cemin C, Vaccarini C, Vergara G. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular de-fibrillator in reducing hospitalizations in patients with heart failure: a case-control study. J Interv Card Electrophysiol 2007;19:201-207. (Pubitemid 47573216)
9. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hos-pitalization. Circulation 2005;112:841-848. (Pubitemid 41170070)
10. Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 2011; doi:10.1093/eurheartj/ehr1050.
11. Wang L. Fundamentals of intrathoracic impedance monitoring in heart failure. Am J Cardiol 2007;99:3G-10G.
12. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574-581. (Pubitemid 32772099)
13. Mullens W, Abrahams Z, Skouri HN, Taylor DO, Starling RC, Francis GS, Young JB, Tang WH. Prognostic evaluation of ambulatory patients with advanced heart failure. Am J Cardiol 2008;101:1297-1302.
14. Rademaker MT, Charles CJ, Melton IC, Richards AM, Frampton CM, Siou J, Qu F, Eigler NL, Gutfinger D, Troughton RW. Monitoring of heart failure: comparison of left atrial pressure with intrathoracic impedance and natriuretic peptide measurements in an experimental model of ovine heart failure. Clin Sci (Lond) 2011; 120:207-217.
15. Vanderheyden M, Houben R, Verstreken S, Stahlberg M, Reiters P, Kessels R, Braunschweig F. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure. Circ Heart Fail 2010;3:370-377.
16. Maines M, Catanzariti D, Cirrincione C, Valsecchi S, Comisso J, Vergara G. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration. Europace 2010;12:680-685.
17. Tomasi L, Zanotto G, Zanolla L, Golia G, Ometto R, Bonanno C, Vergara G, Maines M, Lonardi G, Visentin E, Rauhe W, Latina L, Perrone C, Varbaro A, De Santo T. Physiopathologic Correlates of Intrathoracic Impedance in Chronic Heart Failure Patients. Pacing Clin Electrophysiol 2011;34:407-413.
18. Luthje L, Vollmann D, Drescher T, Schott P, Zenker D, Hasenfuss G, Unterberg C. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP. Eur J Heart Fail 2007;9:716-722. (Pubitemid 46702828)
19. Mullens W, Oliveira LP, Verga T, Wilkoff BL, Tang WH. Insights from internet-based remote intrathoracic impedance monitoring as part of a heart failure disease management program. Congest Heart Fail 2010;16:159-163.
20. Ip JE, Cheung JW, Park D, Hellawell JL, Stein KM, Iwai S, Liu CF, Lerman BB, Markowitz SM. Temporal Associations Between Thoracic Volume Overload and Malignant Ventricular Arrhythmias: A Study of Intrathoracic Impedance. J Cardiovasc Electrophysiol 2011;22:293-299.
21. Moore HJ, Peters MN, Franz MR, Karasik PE, Singh SN, Fletcher RD. Intrathoracic impedance preceding ventricular tachyarrhythmia episodes. Pacing Clin Electrophy-siol 2010;33:960-966.
22. Andriulli J. Device monitoring of intrathoracic impedance: clinical observations from a patient registry. Am J Cardiol 2007;99:23G-28G.
23. Rathman LD, Lee CS, Sarkar S, Small RS. A critical link between heart failure self-care and intrathoracic impedance. J Cardiovasc Nurs 2010; doi:2010.1097/JCN.2010b2013e3181ee2028c2018.
24. Brachmann J, Bohm M, Rybak K, Klein G, Butter C, Klemm H, Schomburg R, Siebermair J, Israel C, Sinha AM, Drexler H, on behalf of the OptiLink HFSEBaI. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Heart Fail 2011;13:796-804.